ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2013-5-13-17ssmu-247Research ArticleМЕЖДИСЦИПЛИНАРНЫЕ ФУНДАМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ В МЕДИЦИНЕNTERDISCIPLINARY BASIC RESEARCH IN MEDICINEАТИПИЧНЫЕ ФОРМЫ РАССЕЯННОГО СКЛЕРОЗА В ТОМСКОЙATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGIONАлифироваВ. М.AlifirovaV. M.

Доктор медицинских наук, профессор, зав. кафедрой неврологии и нейрохирургии

ev.terskikh@gmail.comТитоваМ. А.TitovaM. A.

Кандидат медицинских наук, ассистент кафедры неврологии и нейрохирургии

ev.terskikh@gmail.comТерскихЕ. В.TerskikhE. V.

Клинический ординатор кафедры неврологии и нейрохирургии

ev.terskikh@gmail.comМусинаН. Ф.MusinaN. F.

Кандидат медицинских наук, доцент кафедры неврологии и нейрохирургии

ev.terskikh@gmail.comСибирский государственный медицинский университет, ТомскРоссияSiberian State Medical University, TomskRussian Federation2013281020131251317Copyright © Алифирова В.М., Титова М.А., Терских Е.В., Мусина Н.Ф., 20132013Алифирова В.М., Титова М.А., Терских Е.В., Мусина Н.Ф.Alifirova V.M., Titova M.A., Terskikh E.V., Musina N.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/247

Обследовано 280 пациентов в возрасте от 10 до 70 лет с достоверным диагнозом «рассеянный склероз» (РС) согласно критериям Мак-Доналда. Среди них у 6 (2,1%) больных заболевание впервые  проявило себя в возрасте старше 45; у 18 (6,4%) – ранее 20 лет. У 7 (2,5%) больных диагностировано злокачественное течение РС; у 30 (10,7%) – мягкое течение. 

The study involved 280 patients aged 10 to 70 years old with a valid diagnosis of multiple sclerosis according to the McDonald criteria. There  are 6 (2.1%) patients had the first manifestation of disease overthe age of 45, 18 (6.4%) – 20 years earlier. In 7 (2.5%) of patients diagnosed with malignant progressof the MS, in 30 (10.7%) – soft progress.

рассеянный склерозварианты теченияатипичные формыmultiple sclerosisvariants of the courseatypical formsReferencesШмидт Т.Е., Яхно Н.Н. Рассеянный склероз: руководство для врачей. М.: МЕДпресс-информ, 2010. 272 с.Schmidt T.Ye., Yakhno N.N. Multiple sclerosis: a guide for physicians. Moscow, MEDpress-Inform Publ., 2010. 272 p. (in Russian).McDonald W.I., Comston A., Edan G. et al. Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis // Ann. Neurol. 2000. V.50. P. 121–127.McDonald W.I., Comston A., Edan G. et al. Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann. Neurol., 2000, vol. 50, pp. 121–127.Polman C.H., Reingold S.C., Banwell B. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria // Ann. Neurol. 2011. V. 69 (2). P. 292–302.Polman C.H., Reingold S.C., Banwell B., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol., 2011, vol. 69 (2), pp. 292–302.Cazzullo C.L., Ghezzi A., Marforio S. et al. Clinical picture of multiple sclerosis with late onset // Acta Neurol. Scand. 1978. V. 58. P. 190–196.Cazzullo C.L., Ghezzi A., Marforio S. et al. Clinical picture of multiple sclerosis with late onset. Acta. Neurol. Scand., 1978, vol. 58, pp. 190–196.Thompson A.J., Montalban X., Barkhof F. et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper // Ann. Neurol. 2000. V. 47. P. 831–835.Thompson A.J., Montalban X., Barkhof F. et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann. Neurol., 2000, vol. 47, pp. 831–835.Kis B., Rumberg B., Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis // J. Neurol. 2008. V. 255. P. 697–702.Kis B., Rumberg B., Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis. J. Neurol., 2008, vol. 255, pp. 697–702.Amato M.P., Goretti B., Ghezzi A. et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up // Neurology. 2010. V. 75 (13). P. 1134–1340.Amato M.P., Goretti B., Ghezzi A., et al. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology, 2010, vol. 75 (13), pp. 1134–1340.Lu T., Pan Y., Kao S.Y. et al. Gene regulation and DNA damage in the ageing human brain // Nature. 2004. V. 429. P. 883–891.Lu T., Pan Y., Kao S.Y. et al. Gene regulation and DNA damage in the ageing human brain. Nature, 2004, vol. 429, pp. 883–891.Sim F.J., Zhao C., Penderis J. et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation // J. Neurosci. 2002. V. 22. P. 245–249.Sim F.J., Zhao C., Penderis J., et al. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J. Neurosci., 2002, vol. 22, pp. 245–249.Wolfson C., Wolfson D.B. The latent period of multiple sclerosis: a critical review // Epidemiology. 1993. V. 4. P. 464– 470.Wolfson C., Wolfson D.B. The latent period of multiple sclerosis: a critical review. Epidemiology, 1993, vol. 4, pp. 464–470.Haines J.L., Ter-Minassian M., Bazyk A. et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex: the Multiple Sclerosis Genetics Group // Nat. Genet. 1996. V. 13. P. 469–471.Haines J.L., Ter-Minassian M., Bazyk A., et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex: the Multiple Sclerosis Genetics Group. Nat. Genet., 1996, vol. 13, pp. 469–471.Hooge J.P., Redekop W.K. Multiple sclerosis with very late onset // Neurology. 1992. V. 42. P. 1907–1910.Hooge J.P., Redekop W.K. Multiple sclerosis with very late onset. Neurology, 1992, vol. 42, pp. 1907–1910.Noseworthy J., Paty D., Wonnacott T. et al. Multiple sclerosis after age of 50 // Neurology. 1983. V. 33. P. 1537–1544.Noseworthy J., Paty D., Wonnacott T. et al. Multiple sclerosis after age of 50. Neurology, 1983, vol. 33, pp. 1537–1544.Polliack M.L., Barak Y., Achiron A. Late onset multiple sclerosis // J. Am. Geriatr. Soc. 2001. V. 49. P. 168–171.Polliack M.L., Barak Y., Achiron A. Late onset multiple sclerosis. J. Am. Geriatr. Soc., 2001, vol. 49, pp. 168–171.Frischer J.M., Bramow S., Dal-Bianco A. et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains // Brain. 2009. V. 132. P. 1175–1189.Frischer J.M., Bramow S., Dal-Bianco A., et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain, 2009, vol. 132, pp. 1175–1189.

The authors declare that there are no conflicts of interest present.